Below are links to eighteen publications describing clinical studies of ASPS with novel treatments as well as preclinical information on ASPS.
The ASPS community is thankful to all the Principle Investigators, Oncologists and Researchers who are working with us to find a cure for ASPS!
- Anlotinib with Toripalimab for ASPS Therapy
- Complete Response of Metastatic ASPS Treated by Combined Immune Checkpoint Inhibitors
- Review of Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas
- Response of ASPS to Pembrolizumab After Carbon Ion Radiation Therapy
- Activity of PD-1 Inhibitor Combined with Anti-Angiogenic Therapy in Advanced Sarcoma
- Review of Stereotactic Radiosurgery in ASPS Brain Metastases
- The Current Management of ASPS
- Advances in the Management of ASPS
- Target Therapy for Metastatic ASPS: A Retrospective Study with 47 Cases
- Gene of the month: TFE 3
- Analysis of Phase II Trials: PD1/PD-L1 Targeting in Advanced Soft Tissue Sarcomas
- Cediranib Phase II Study in Children with Metastatic ASPS
- Cediranib in ASPS (CASPS): A Double-Blind, Placebo-Controlled, Randomised, Phase 2 Trial
- Efficacy and Safety of Apatinib in ASPS
- Axitinib plus pembrolizumab in Patients with Advanced Sarcomas Including ASPS
- Effective Treatment of ASPS with sunitinib
- Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft- Tissue Sarcoma
- Activity and Safety of Crizotinib in ASPS phase II trial